Literature DB >> 8224052

Component-specific effects of physostigmine on the cat visual evoked potential.

K Arakawa1, N S Peachey, G Celesia, G Rubboli.   

Abstract

Pattern visual evoked potentials (VEPs) were recorded from the pial surface of the cat primary visual cortex prior to and following the intravenous administration of physostigmine, an agent which blocks the enzyme responsible for the breakdown of synaptically released acetylcholine. The control VEP was composed of a small initial positive deflection (P1), a subsequent large negative wave (N1) and a second large positive wave (P2). Following physostigmine, the amplitude of P1-N1 was diminished whereas that of N1-P2 increased. These effects were long lasting and were blocked by prior treatment with scopolamine, a result consistent with mediation by a muscarinic cholinergic pathway. Waveform subtraction revealed that the physostigmine-sensitive component had a slow, negative polarity waveform while the physostigmine-insensitive component was also slow, but positive in polarity. The fundamental nature of these components remains to be assessed. Nevertheless, the results indicate that waveforms of different polarity combine algebraically to yield the conventional VEP.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8224052     DOI: 10.1007/bf00229785

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  21 in total

1.  The extrastriate generators of the EP to checkerboard onset. A source localization approach.

Authors:  P Ossenblok; H Spekreijse
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1991 May-Jun

Review 2.  Chemically specified systems in the dorsal lateral geniculate nucleus of mammals.

Authors:  P Pasik; R Molinar-Rode; T Pasik
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1990

3.  Spatial frequency response functions obtained from cat visual evoked potentials.

Authors:  K Arakawa; N S Peachey; G G Celesia
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1993 Mar-Apr

4.  Modifications of the pattern-evoked potential (PEP) in relation to the stimulated part of the visual field (clues for the most probable origin of each component).

Authors:  N Lesevre; J P Joseph
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1979-08

5.  Source locations of pattern-specific components of human visual evoked potentials. I. Component of striate cortical origin.

Authors:  D A Jeffreys; J G Axford
Journal:  Exp Brain Res       Date:  1972       Impact factor: 1.972

6.  Refraction determined electrophysiologically. Responses to alternation of visual contours.

Authors:  M Millodot; L A Riggs
Journal:  Arch Ophthalmol       Date:  1970-09

7.  Principal components analysis for source localization of VEPs in man.

Authors:  J Maier; G Dagnelie; H Spekreijse; B W van Dijk
Journal:  Vision Res       Date:  1987       Impact factor: 1.886

8.  Intracortical generators of the flash VEP in monkeys.

Authors:  M A Kraut; J C Arezzo; H G Vaughan
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1985-07

9.  Stationary pattern adaptation and the early components in human visual evoked potentials.

Authors:  H K Hudnell; W K Boyes; D A Otto
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1990 May-Jun

10.  A cholinergic-sensitive channel in the cat visual system tuned to low spatial frequencies.

Authors:  T H Harding; R W Wiley; A W Kirby
Journal:  Science       Date:  1983-09-09       Impact factor: 47.728

View more
  2 in total

1.  Effects of repetitive TMS on visually evoked potentials and EEG in the anaesthetized cat: dependence on stimulus frequency and train duration.

Authors:  Selcen Aydin-Abidin; Vera Moliadze; Ulf T Eysel; Klaus Funke
Journal:  J Physiol       Date:  2006-05-11       Impact factor: 5.182

2.  Expression of early growth responsive gene-1 in the visual cortex of monocular form deprivation amblyopic kittens.

Authors:  Haobo Fan; Ying Wang; Xiuping Tang; Liyuan Yang; Weiqi Song; Yunchun Zou
Journal:  BMC Ophthalmol       Date:  2021-11-15       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.